Thursday, June 24, 2010

Axxess Pharma, Inc. Signs Letter of Intent (LOI) to Acquire Pharmaceutical Manufacturer

Axxess Pharma, Inc. Signs Letter of Intent (LOI) to Acquire Pharmaceutical Manufacturer and Add Over $2 Million in Annual Revenue to Axxess Pharmas Financials

Ontario, CA, June 28, 2010 – Axxess Pharma, Inc AXXE.PK a pharmaceutical company specializing in the marketing and distribution of both prescription and non-prescription medical products in a multi-billion dollar industry is pleased to announce they have signed a Letter of Intent (LOI) to acquire a Canadian based pharmaceutical manufacturer. The acquisition will add over $2 million in annual revenues to Axxess Pharma, Inc’s financials.
The Companies facility is roughly 22,000 square feet and manufactures pharmaceuticals, neutroceuticals and dermotologicals.  Axxess Pharma will continue the distribution of its own line of pharmaceuticals from its Markham location.
“This is an exciting time for our company. We anticipate completing the acquisition of the pharmaceutical manufacturer in the very near future. The acquisition will add over $2 million in annual sales to our financials, provide us with a large manufacturing facility and new product lines.” stated Gerald Sequeira, President/CEO. “This is one more sign that we are focused on continuing to expand our operations across Canada and gain market share. We will have lots of information for our shareholders in the upcoming weeks. This information will define where we are and what is new and happening with Axxess Pharma.” stated Gerald Sequeira, President/CEO.
For more information
About Axxess Pharma, Inc.:

Axxess Pharma, Inc. is a specialty pharmaceutical company that focuses on the marketing of dermatological, therapeutic nutritionals, pain management and diagnostic products in Canada and abroad since 1997. Axxess owns 22 established pharmaceutical prescription products that have proven sales in Canada and internationally. The company has an experienced management team and field sales force to market products nationally to hospitals and retail pharmacies as well as specialized practice areas including Dermatology and Nephrology,Neurology and Urology.

No comments: